Let me know when the data is updated again

LARONIDASA

PRODUCT SUMMARY

This product had 6 purchases (29,119 units) for a total of 245 millones pesos mexicanos (245,000,129.43 MXN) between 2009 and 2012 with an overcost of 3.1 millones pesos mexicanos (3,057,323.566 MXN) that would have made it possible to buy 356.9 additional units.

Description

LARONIDASA. SOLUCION INYECTABLE. CADA FRASCO AMPULA CONTIENE: LARONIDASA 2.9 MG (500 U). ENVASE CON FRASCO AMPULA CON 5 ML (2.9 MG O 500 U).

Average price

8,413.8 pesos mexicanos

IMSS product code

010.000.5547.01

PRICE DISPERSION

Each circle represents one of the 6 purchases of LARONIDASA made by the IMSS between 2009 and 2012.

OVERCOST BY INSTITUTION

INSTITUTION STATE QUANTITY TOTAL AMOUNT OVERCOST IN MXN OVERCOST IN % LOST QUANTITY LAST PURCHASE
Oficinas Centrales Almacen De Programas Especiales Y Red Fria 4 144 millones MXN 3.1 millones MXN 1.25 % 356.9 31 de diciembre de 2010
Oficinas Centrales Ofnas Centrales -reforma- Coordinacion De Abastecimiento 2 101 millones MXN - MXN - - 18 de julio de 2012

SUPPLIERS THAT HAVE SOLD IT AT AN OVERPRICE

SUPPLIER PURCHASES OVERCOST IN MXN OVERCOST IN % LOST QUANTITY TIME PERIOD
GENZYME CORPORATION 3 3.1 millones MXN 1.67 % 356.9 2009 - 2010
GENZYME MEXICO, S. DE R. L. DE C. V. 3 - MXN - - 2010 - 2012
There are 6 purchases of this medicine in total.
SEE ALL PURCHASES

GENERAL INFORMATION

Date updated in QQW

3 de octubre de 2022

Source(s)

comprasimss

Part of the project

Salud, Dinero y Corrupción

Organization responsible for the import

PODER